Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? (Q34980806)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? |
scientific article |
Statements
1 reference
Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? (English)
1 reference
T J Cawood
1 reference
P J Hunt
1 reference
D O'Shea
1 reference
D Cole
1 reference
S Soule
1 reference
13 May 2009
1 reference
1 reference
161
1 reference
4
1 reference
513-527
1 reference
Identifiers
1 reference
1 reference